Explore Volv Global case studies to see how AI helps find patients, detect diseases earlier, and improve outcomes across healthcare.
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes research to explore the future…
How AI-driven insights from RWD accelerate the diagnosis and treatment of undiagnosed patients: A case study in alpha-1 antitrypsin deficiency…
Volv Global presented two posters at ATS 2025, in collaboration with Takeda The posters were the result of work to…
Alpha-1 antitrypsin deficiency (AATD) Alpha-1 antitrypsin deficiency (AATD) is a rare genetic condition which can cause lung disease in adults…
By Christopher Rudolf, Volv Global An AI Methodology for Finding Patients with Rare Diseases: Volv Global’s inTrigue Finding patients with…
Volv, supported by Sanofi, and working with Optimum Patient Care, and collaborating with a specialist Consultant Clinician, is performing research…